Skip to Content

Avivagen Inc - Stock Quote VIVXF

Rating as of

Morningstar's Avivagen Inc Stock Analysis

Valuation
Currency in USD
Is it the right time to buy or sell?
Is it the right time to buy or sell?

1-Star Price

INVESTOR

5-Star Price

INVESTOR

Economic Moat

INVESTOR

About Quantitative Ratings

Morningstar Quantitative ratings for equities (denoted on this page by) are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies withratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating. Click here for more on how to use these ratings.

Key Statistics - VIVXF

Avivagen Inc's Company Profile

Business Description

Avivagen Inc is a Canadian based company operating in the healthcare sector. It develops science-based, natural health products for animals. It develops and commercializes products for livestock feeds to replace antibiotics for growth promotion and to help prevent disease by supporting the animal's health defenses. The company's products are based on OxC-beta Technology. Its geographical segments include the Philippines, which is the key revenue driver; Mexico; Thailand; United States; Malaysia; Taiwan; Brazil; and others.

Contact
100 Sussex Drive
Ottawa, ON, K1A 0R6, Canada
T +1 613 990-0969
Industry Drug Manufacturers - Specialty & Generic
Most Recent Earnings Apr 30, 2022
Fiscal Year End Oct 31, 2021
Stock Type
Employees 13